Newsletter Subject

Why Women’s Life Expectancy Is Six Years Longer Than Men

From

longr.io

Email Address

hello@reads.longr.io

Sent On

Thu, Nov 16, 2023 12:23 AM

Email Preheader Text

Your daily digest on longevity, investment, science & lifestyle ͏  ͏  ͏

Your daily digest on longevity, investment, science & lifestyle ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ November 15th, 2023 | [Read Online]( Good Morning , Welcome to this week's edition of our longevity-focused newsletter, where we delve into the latest scientific insights and research that are shaping our understanding of life extension and healthspan enhancement. This issue brings to light the startling gender disparities in life expectancy, as recent findings reveal a widening gap with American women outliving men by nearly six years. We explore the underlying causes, from the COVID-19 pandemic to the opioid crisis, and the urgent call for gender-specific healthcare interventions. Shifting gears, we examine the unexpected potential of metformin, a common diabetes drug, in its new role as a possible elixir for aging. This marks a significant pivot in medical research, opening doors to novel anti-aging therapies. Lastly, we uncover the surprising benefits of coffee, a staple in many diets, in promoting longevity and combating various diseases, redefining our perspective on everyday health choices. Join us as we navigate these intriguing developments, offering a comprehensive view of the dynamic field of longevity research and its implications for our health and future. Grab yourself a brew... EVERY WEDNESDAY Research Round-up Women’s Life Expectancy Six Years Longer Than Men A recent study by UCSF and Harvard T.H. Chan School of Public Health reveals a concerning trend in U.S. life expectancy: the gender gap is widening to its largest since 1996. As of 2021, American women outlive men by 5.8 years, a significant increase from a 4.8-year gap in 2010. This disparity, detailed in a JAMA Internal Medicine publication on November 13, 2023, is primarily driven by the COVID-19 pandemic and the opioid overdose epidemic, disproportionately affecting men. Men's higher mortality rates from the pandemic, accidental injuries, drug overdoses, and suicides call for urgent gender-specific healthcare interventions. The research, led by Brandon Yan, underscores the need for specialized care, especially in mental health for men, to address this expanding life expectancy gap. This study highlights the criticality of adapting public health strategies to reverse this worrying trend. [Neuroscience News]( The most striking discovery was in the elderly, where taurine levels were a staggering 80% lower than in their younger counterparts. This nutrient's potential seems promising, especially when considering its ability to add an estimated seven to eight years to human life. Could the Diabetes Drug Metformin Slow the Aging Process? In a groundbreaking exploration, scientists are investigating metformin, a diabetes medication, for its potential to slow aging. Known for regulating insulin, metformin also positively influences various aging pathways. While extensively used for diabetes, it’s now eyed for extending both lifespan and healthspan. Although animal studies show modest life extension, human research suggests significant health benefits, including reduced mortality risks and combating aging-related diseases. Current trials, like TAME, aim to definitively establish metformin's anti-aging effects. Its safety, widespread availability, and affordability make it a promising candidate for public health impact. However, experts advise against its use for anti-aging outside clinical studies, pending more conclusive evidence. Metformin's journey from a diabetes drug to a potential anti-aging marvel reflects an exciting shift in medical research, challenging our understanding of health and longevity. [Everyday Health]( Epidemiological observations have long hinted at a curious phenomenon: populations residing at high altitudes often live longer and seem less susceptible to certain diseases. This study sought to replicate these findings in a controlled animal setting, shedding light on the potential benefits of high-altitude living. Surprising Research Finds Link Between Coffee and Longevity In a pivotal study by Dr. James Thompson and his team at the Health Science Institute, an unexpected link between coffee consumption and longevity has been uncovered. Analyzing over 500,000 health records, they found that regular coffee drinkers have a significantly lower risk of various diseases. The study highlights caffeine's antioxidant properties, which protect cells from free radical damage, potentially reducing the incidence of Alzheimer’s, Parkinson's, liver diseases, heart disease, strokes, certain cancers, and type 2 diabetes. This research challenges previous notions about coffee, suggesting that daily consumption could enhance longevity and health. However, moderation is advised due to possible adverse effects like sleep issues and anxiety. These findings underscore the potential health benefits of everyday foods and beverages, indicating that pleasure and health can coexist. [Times News Global]( Sima, the last surviving rat from the study, stands as a testament to the treatment's potential. She has already surpassed the typical lifespan for her species, drawing parallels to a human living beyond 126 years. In this week's edition of our longevity-focused newsletter, we've delved deep into pivotal research and insights that are reshaping our understanding of life extension. The stark gender disparities in life expectancy, with American women outliving men by nearly six years, highlight an urgent need for gender-specific healthcare interventions. These findings, driven by factors like the COVID-19 pandemic and the opioid crisis, call for a reevaluation of public health strategies to bridge this widening gap. Simultaneously, the potential repurposing of metformin, a diabetes drug, as an anti-aging elixir marks a significant shift in medical research, suggesting new avenues for healthspan enhancement. This is complemented by the unexpected link between coffee consumption and longevity, redefining our perspective on everyday health choices and the role of diet in promoting longevity. These diverse topics collectively underscore the dynamic and ever-evolving field of longevity research. Each study and discovery not only enriches our understanding but also opens up possibilities for innovative approaches to health and well-being. As we continue to explore these developments, they promise to reshape our approach to aging, health, and longevity. Plenty to discuss, The Longr Reads Team. "The science of today is the technology of tomorrow." Edward Teller, Theoretical Physicist Longr Reads' of the Week - The start-ups seeking a cure for old age ([Financial Times]( - Interview: The US tech millionaire trying to reverse his age ([BBC News]( - Inconvenient Truths About Human Longevity ([Oxford Academic]( THE LONGEVITY INVESTOR REPORT This exclusive first edition has a complete sector breakdown, and an introduction to some of the key things professional longevity investors are looking at. [FREE DOWNLOAD]( [FREE LONGEVITY INVESTOR REPORT! CLICK HERE!!]( Longr is building access to longevity across: generative AI, therapeutics, wellness products, clinics, research, community, and marketplaces. Transforming visionary concepts into tangible solutions - we are facilitating widespread adoption of longevity-enhancing products and platforms. [Advertise with us](mailto:partnerships@longr.io) // [Book a call with Longr](mailto:ir@longr.io) 107 North Orange Street, Wilmington, Delaware 19801, United States You received this email from Longr Reads. If you would like to unsubscribe, [click here](.

Marketing emails from longr.io

View More
Sent On

09/06/2024

Sent On

05/06/2024

Sent On

04/06/2024

Sent On

03/06/2024

Sent On

31/05/2024

Sent On

30/05/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.